NVCR- Novocure Limited

Name: Novocure Limited Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Novocure Limited (NVCR) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells. NVCR is classified in the Health Care Equipment & Supplies industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Cordova Ashley	437.6K	$6.10M	-
Dir	Danziger Asaf	416.5K	$5.80M	-
VP	Leonard Frank X	347.7K	$4.84M	-
Other	Ben Arye Barak	174.5K	$2.43M	-
Other	Puri Michal Nath	163.8K	$2.28M	-

Activity

Buys and sells only

Transactions

10 filings · page 18

Date	Insider	Role	Type	Shares	Price	Value	Chg%
May 11, 2020	Benaim Ely73	Chief Medical Officer	Sale+OE	1,611	$63.73	$102,665.81	-9.6%
May 8, 2020	Doyle William F53	Executive Chairman	Sale+OE	62,896	$64.11	$4,032,390.22	-4.5%
May 6, 2020	Doyle William F53	Executive Chairman	Sale+OE	60,164	$63.36	$3,812,170.31	-4.9%
May 5, 2020	Shah Pritesh75	Chief Commercial Officer	Sell	1,149	$62.20	$71,467.80	-1.1%
May 4, 2020	Shah Pritesh75	Chief Commercial Officer	Sale+OE	1,184	$60.08	$71,133.54	-1.1%
Apr 14, 2020	Ambrogi Michael J.	Chief Operating Officer	Sale+OE	58,500	$70.11	$4,101,564.20	-6.0%
Mar 6, 2020	Ambrogi Michael J.	Chief Operating Officer	Sell	2,274	$69.53	$158,120.32	-1.0%
Mar 6, 2020	Shah Pritesh75	Chief Commercial Officer	Sale+OE	6,151	$66.76	$410,621.95	-3.2%
Mar 6, 2020	Doyle William F53	Executive Chairman	Sell	4,320	$69.53	$300,386.88	-0.8%
Mar 6, 2020	Longsworth Todd Christopher	General Counsel	Sell	2,499	$69.53	$173,765.47	-2.8%

← PrevPage 18Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC